Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Fulgent Genetics, Inc. (NASDAQ: FLGT)
FLGT Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
9.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
3.20%
FLGT Stock Analysis
FLGT
PE Ratio:
FLGT
PEG Ratio:
Not Available
FLGT
Forward EPS Growth (12 month):
0.00%
FLGT
PS Ratio:
1.6
FLGT
PSG Ratio:
0.1
FLGT
Forward Revenue Growth (12 month):
14.70%
FLGT Articles
No data was found